PV pharm branch, vendor, cage 0U9U0
Ended Awarded
- Contract number
- SPE2D825FA9YC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $15,077
Award facts
- Contract value 100% obligated
- $15,077.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $15,077.16 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made on a competitive basis with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems.
Under this delivery order, AmerisourceBergen will supply pharmaceutical products and medical commodities to support the Defense Logistics Agency's medical supply requirements. The contract leverages AmerisourceBergen's comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's firm fixed-price delivery orders with DLA typically range significantly in value, demonstrating its capability to fulfill federal medical supply needs efficiently. This award reflects AmerisourceBergen's ongoing role as a preferred vendor within the DLA's Pharmaceutical Prime Vendor program, which enables flexible and responsive pharmaceutical support for military healthcare operations globally.
Quick answers
Who was awarded contract SPE2D825FA9YC?
SPE2D825FA9YC was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on August 11, 2025.
How much is contract SPE2D825FA9YC worth?
The government has obligated $15,077 on SPE2D825FA9YC.
Is contract SPE2D825FA9YC an order under another contract?
Yes. SPE2D825FA9YC is a delivery order under SPE2DX22D0049, an indefinite delivery contract.
Was contract SPE2D825FA9YC competed?
The extent of competition for SPE2D825FA9YC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award